Zobrazeno 1 - 10
of 54
pro vyhledávání: '"F F Horber"'
Publikováno v:
Casez, Jean-Paul; Lippuner, Kurt; Horber, Fritz F; Montandon, André; Jaeger, Philippe (2002). Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone. Nephrology, dialysis, transplantation, 17(7), pp. 1318-26. Oxford: Oxford University Press 10.1093/ndt/17.7.1318
Background. Prednisone is a major factor of bone loss after kidney transplantation. The role of hyperparathyroidism and immunosuppressors is less clear. Methods. Thirty‐three patients (14 men, 19 women) with ESRD were followed prospectively for 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::576ed99fcad37e605e49f850d42f84c1
http://doc.rero.ch/record/294837/files/171318.pdf
http://doc.rero.ch/record/294837/files/171318.pdf
Publikováno v:
Journal of Bone and Mineral Research. 9:1-9
Renal transplant patients exhibit increased rates of trabecular bone fractures, probably due to glucocorticoid-induced osteopenia, which is known to occur within 6 months after kidney grafting. This mineral loss at a mostly trabecular site (lumbar sp
Autor:
F. F. Horber, Martin Schneider, Claudio Graf, Regina Michel, Kurt Laederach-Hofmann, Sandra Lederer, Kurt Lippuner
Publikováno v:
International Journal of Eating Disorders. 26:231-244
This study with 31 obese binge eaters (body mass index [BMI] 39.5+/-8.6 kg/m(2) [SD]) was designed to assess whether diet counseling with psychological support and imipramine or placebo has an effect on the frequency of binge eating, body weight, and
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:3795-3802
To compare the effects of deflazacort (DEFLA) vs. prednisone (PRED) on bone mineral density (BMD), body composition, and lipids, 24 patients with end-stage renal disease were randomized in a double blind design and followed 78 weeks after kidney tran
Publikováno v:
Clinical Endocrinology. 48:691-699
To compare the effects on body composition and body weight of tibolone vs two different sequential oral or transdermal oestrogen-progestogen hormone replacement therapies versus no therapy.One hundred postmenopausal women were assigned to a control g
Publikováno v:
Nutrition. 13:524-534
The mechanism(s) governing the gain of upper-body fat and its relationship to the decrease in bone mass with age is still unclear. Therefore, four groups of subjects matched for weight, height, and body mass index (n = 119; 60 women, 59 men), but dif
Publikováno v:
European Journal of Clinical Investigation. 25:809-816
Kidney transplant patients display decreased muscle mass and increased fat mass. Whether this altered body composition is due to glucocorticoid induced altered fuel metabolism is unclear. To answer this question, 16 kidney transplant patients were ex
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 79:1701-1705
Several endocrine functions have been found disturbed in patients with acquired immunodeficiency syndrome (AIDS). However, no information is available on parathyroid function in these patients. Six patients with AIDS and 10 healthy volunteers underwe
Publikováno v:
European Journal of Clinical Investigation. 24:195-200
Glucocorticoid associated altered body fat distribution and muscle wasting are well known following kidney grafting. Whether an immunosuppressive regimen after glucocorticoid withdrawal (i.e. monotherapy with cyclosporine A (CsA)) is associated with
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 75:1192-1197
The in vivo effects of recombinant human insulin-like growth factor-I (rhIGF-I) on whole body protein metabolism were studied to ascertain whether rhIGF-I has comparable effects as those reported with rhGH use in humans. The doses of rhIGF-I chosen a